Giovanni Salvatori

3.9k total citations
32 papers, 2.5k citations indexed

About

Giovanni Salvatori is a scholar working on Immunology, Molecular Biology and Genetics. According to data from OpenAlex, Giovanni Salvatori has authored 32 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Immunology, 14 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in Giovanni Salvatori's work include Biomarkers in Disease Mechanisms (18 papers), Virus-based gene therapy research (7 papers) and CAR-T cell therapy research (4 papers). Giovanni Salvatori is often cited by papers focused on Biomarkers in Disease Mechanisms (18 papers), Virus-based gene therapy research (7 papers) and CAR-T cell therapy research (4 papers). Giovanni Salvatori collaborates with scholars based in Italy, Switzerland and United States. Giovanni Salvatori's co-authors include Alberto Mantovani, Barbara Bottazzi, Cecília Garlanda, Andrea Doni, Antonio Bastone, Luigina Romani, Antonietta Salustri, Rita De Santis, Anthony J. Day and Maura Camozzi and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Giovanni Salvatori

32 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Giovanni Salvatori Italy 24 1.5k 1.0k 276 270 193 32 2.5k
Nicolas S. Merle France 13 1.6k 1.1× 668 0.7× 254 0.9× 98 0.4× 187 1.0× 34 2.5k
Harald G. Foellmer United States 21 828 0.6× 502 0.5× 320 1.2× 159 0.6× 361 1.9× 27 2.0k
Federica Moalli Italy 25 1.5k 1.0× 526 0.5× 190 0.7× 106 0.4× 63 0.3× 35 2.2k
L D Shultz United States 17 1.5k 1.0× 621 0.6× 189 0.7× 428 1.6× 108 0.6× 30 2.7k
Davide Salina Canada 10 1.6k 1.1× 1.2k 1.2× 203 0.7× 239 0.9× 101 0.5× 16 2.5k
Gerhild Wildner Germany 33 860 0.6× 429 0.4× 105 0.4× 140 0.5× 207 1.1× 90 2.4k
Seema R. Patel United States 23 1.1k 0.8× 560 0.6× 175 0.6× 279 1.0× 133 0.7× 54 2.5k
Suzanne B. Hartley United States 14 2.9k 2.0× 633 0.6× 116 0.4× 307 1.1× 147 0.8× 14 3.5k
Marie‐Cécile Michallet France 21 1.2k 0.8× 1.2k 1.2× 372 1.3× 101 0.4× 320 1.7× 51 2.5k
Amos Orlofsky United States 24 1.1k 0.7× 842 0.8× 87 0.3× 138 0.5× 129 0.7× 34 2.1k

Countries citing papers authored by Giovanni Salvatori

Since Specialization
Citations

This map shows the geographic impact of Giovanni Salvatori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Salvatori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Salvatori more than expected).

Fields of papers citing papers by Giovanni Salvatori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giovanni Salvatori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Salvatori. The network helps show where Giovanni Salvatori may publish in the future.

Co-authorship network of co-authors of Giovanni Salvatori

This figure shows the co-authorship network connecting the top 25 collaborators of Giovanni Salvatori. A scholar is included among the top collaborators of Giovanni Salvatori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giovanni Salvatori. Giovanni Salvatori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luberto, Laura, Bruna Neroni, Orietta Gandini, et al.. (2021). Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections. Frontiers in Microbiology. 12. 789774–789774. 1 indexed citations
2.
Salvatori, Giovanni, Laura Luberto, Mariano Maffei, et al.. (2020). SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines. Journal of Translational Medicine. 18(1). 222–222. 132 indexed citations
3.
Marra, Emanuele, et al.. (2014). Efficacy of PTX3 and Posaconazole Combination in a Rat Model of Invasive Pulmonary Aspergillosis. Antimicrobial Agents and Chemotherapy. 58(10). 6284–6286. 10 indexed citations
4.
Lindstedt, Ragnar, Antonio Inforzato, Antonella Camaioni, et al.. (2011). Implication of the oligomeric state of the N-terminal PTX3 domain in cumulus matrix assembly. Matrix Biology. 30(5-6). 330–337. 38 indexed citations
5.
Inforzato, Antonio, Clair Baldock, Thomas A. Jowitt, et al.. (2010). The Angiogenic Inhibitor Long Pentraxin PTX3 Forms an Asymmetric Octamer with Two Binding Sites for FGF2. Journal of Biological Chemistry. 285(23). 17681–17692. 100 indexed citations
6.
Santis, Rita De, Barbara Leoni, Fiorella Petronzelli, et al.. (2009). OXavidin for Tissue Targeting Biotinylated Therapeutics. BioMed Research International. 2009(1). 921434–921434. 14 indexed citations
7.
Inforzato, Antonio, Vincenzo Rivieccio, Antonio Morreale, et al.. (2008). Structural Characterization of PTX3 Disulfide Bond Network and Its Multimeric Status in Cumulus Matrix Organization. Journal of Biological Chemistry. 283(15). 10147–10161. 115 indexed citations
8.
Camaioni, Antonella, Barbara Bottazzi, Andrea Doni, et al.. (2007). PTX3 Interacts with Inter-α-trypsin Inhibitor. Journal of Biological Chemistry. 282(41). 30161–30170. 129 indexed citations
9.
Presta, Marco, Maura Camozzi, Giovanni Salvatori, & Marco Rusnati. (2007). Role of the soluble pattern recognition receptor PTX3 in vascular biology. Journal of Cellular and Molecular Medicine. 11(4). 723–738. 152 indexed citations
10.
Bozza, Silvia, Francesco Bistoni, Roberta Gaziano, et al.. (2006). Pentraxin 3 protects from MCMV infection and reactivation through TLR sensing pathways leading to IRF3 activation. Blood. 108(10). 3387–3396. 105 indexed citations
11.
Bottazzi, Barbara, Cecília Garlanda, Giovanni Salvatori, et al.. (2005). Pentraxins as a key component of innate immunity. Current Opinion in Immunology. 18(1). 10–15. 141 indexed citations
12.
Nauta, Alma J., Barbara Bottazzi, Alberto Mantovani, et al.. (2003). Biochemical and functional characterization of the interaction between pentraxin 3 and C1q. European Journal of Immunology. 33(2). 465–473. 284 indexed citations
13.
Hartigan-O’Connor, Dennis J., Catherine Barjot, Giovanni Salvatori, & Jeffrey S. Chamberlain. (2002). [13] Generation and growth of gutted adenoviral vectors. Methods in enzymology on CD-ROM/Methods in enzymology. 346. 224–246. 24 indexed citations
14.
Barjot, Catherine, Dennis J. Hartigan-O’Connor, Giovanni Salvatori, Jeannine M. Scott, & Jeffrey S. Chamberlain. (2002). Gutted adenoviral vector growth using E1/E2b/E3‐deleted helper viruses. The Journal of Gene Medicine. 4(5). 480–489. 25 indexed citations
15.
Cossu, Giulio, L. De Angelis, Ugo Borello, et al.. (2000). Determination, diversification and multipotency of mammalian myogenic cells. The International Journal of Developmental Biology. 44(6). 699–706. 23 indexed citations
16.
Berghella, Libera, L. De Angelis, M. Coletta, et al.. (1999). Reversible Immortalization of Human Myogenic Cells by Site-Specific Excision of a Retrovirally Transferred Oncogene. Human Gene Therapy. 10(10). 1607–1617. 37 indexed citations
17.
Lattanzi, Laura, Giovanni Salvatori, M. Coletta, et al.. (1998). High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies.. Journal of Clinical Investigation. 101(10). 2119–2128. 117 indexed citations
18.
Tiainen, Marianne, Deborah Pajalunga, Flavia Ferrantelli, et al.. (1996). Terminally differentiated skeletal myotubes are not confined to G0 but can enter G1 upon growth factor stimulation.. PubMed. 7(8). 1039–50. 44 indexed citations
19.
Ferrari, Giuliana, Giovanni Salvatori, Claudia Rossi, Giulio Cossu, & Fulvio Mavilio. (1995). A Retroviral Vector Containing a Muscle-Specific Enhancer Drives Gene Expression Only in Differentiated Muscle Fibers. Human Gene Therapy. 6(6). 733–742. 43 indexed citations
20.
Salvatori, Giovanni, Giuliana Ferrari, Antonio Mezzogiorno, et al.. (1993). Retroviral Vector-Mediated Gene Transfer into Human Primary Myogenic Cells Leads to Expression in Muscle Fibers In Vivo. Human Gene Therapy. 4(6). 713–723. 47 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nicolas S. Merle Breakdown of academic impact, for papers by Harald G. Foellmer Breakdown of academic impact, for papers by Federica Moalli Breakdown of academic impact, for papers by L D Shultz Breakdown of academic impact, for papers by Davide Salina Breakdown of academic impact, for papers by Gerhild Wildner Breakdown of academic impact, for papers by Seema R. Patel Breakdown of academic impact, for papers by Suzanne B. Hartley Breakdown of academic impact, for papers by Marie‐Cécile Michallet Breakdown of academic impact, for papers by Amos Orlofsky
Rankless by CCL
2026